参考文献/References:
1 Bartucci M,M orelli C,Mauro L,et al.Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.Cancer Res,2001,61(18):6747-6754.
2 Macaulay VM,Salisbury A J,Bohula EA,et al.Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of Atm kinase.Oncogene,2001,20(30):4029-4040.
3 Peretz S,Jensen R,Baserga R,et al.ATM-dependent expression of the insulin-like growth factor-1 receptor in a pathway regulating radiation response.PNAS,2001,98(4):1676-1681.
4 Soderlund K,Perez-Tenorio G,Stal O.Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells.Int J Oncol,2005,26(1):25-32.
5 Sartor CI.Epidermal growth factor family receptors and inhibitors:radiation response modulators.Semin Radiat Oncol,2003,13(1):22-30.
6 Zhou H,Kim YS,Peletier A,et al.Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation,radiosensitization,and resistance.Int J Radiat Oncol Biol Phys,2004,58(2):344-352.
7 Liang K,Lu Y,Jin W,et al.Sensitization of breast cancer cells to radiation by trastuzumab.Mol Cancer Ther,2003,2(11):1113-1120.
8 Gupta VK,Jaskowiak NT,Beckett MA,et al.Vascular endothelial growth factor enhances endothelial cell survival and tumour radioresistance.Cancer,2002,8(1):47-54.
9 Wachsberger P,Burd R,Dicker AP.Tumour response to ionizing radiation combined with antiangiogenesis or vascular targeting agents:exploring mechanisms of interaction.Clin Cancer Res,2003,9(6):1957-1971.
10 Marchetti P,Cannita K,Ricevuto E,et al.Prognostic value of p53 molecular status in high-risk primary breast cancer.Ann Oncol,2003,14(5):704-708.
11 Wachsberger P,Burd R,Dicker AP.Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways.Hematol Oncol Clin North Am,2004,18(5):1039-1057.
12 Couture C,Raybaud-Diogene H,Tetu B,et al.p53 and Ki-67 as markers of radioresistance in head and neck carcinoma.Cancer,2002,94(3):713-722.
13 Enns L,Bogen KT,Wizniak J,et al.Low-dose radiation hypersensitivity is associated with p53-dependent apoptosis.Mol Cancer Res,2004,2(10):557-566.
14 Powell SN,Kachnic LA.Roles of BRCA1 and BRCA2 in homologous recombination,DNA replication fidelity and the cellular response to ionizing radiation.Oncogene,2003,22(37):5784-5791.
15 Xia F,Taghian DG,DeFrank JS,et al.Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining.Proc Natl Acad Sci USA,2001,98(15):8644-8649.
16 Lear-Kaul KC,Yoon HR,Kleinschmidt-DeMasters BK,et al.Her2/neu status in breast cancer metastases to the central nervous system.Arch Pathol Lab Med,2003,127(11):1451-1457.
17 Slijepoevic P.Is there a link between telomere maintenance and radiosensitivity?.Radiat Res,2004,161(1):82-86.
18 Provenzano E,Hopper JL,Giles GG,et al.Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast.Eur J Cancer,2003,39(5):622-630.
19 Van’t Veer LJ,Dai H,van de Vijver MJ,et al.Gene expression profiling predicts clinical outcome of breast cancer.Nature,2002,415(6871):530-536.
20 Van de Vijver MJ,He YD,van’t Veer LJ,et al.A geneexpression signature as a predictor of survival in breast cancer.N Engl J Med,2002,347(25):1999-2009.
相似文献/References:
[1]杨雷,袁卫红,王家平,等.99Tcm-MIBI显像与钼靶X线对乳腺癌诊断的比较研究[J].国际放射医学核医学杂志,2016,40(2):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
Yang Lei,Yuan Weihong,Wang Jiaping,et al.Diagnostic value of technetium 99Tcm sestamibi and X-ray mammography in breast cancer: a comparison study[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):111.[doi:10.3760/cma.j.issn.1673-4114.2016.02.005]
[2]马乐,张万春,李晓敏.乳腺癌前哨淋巴结核素显像新进展[J].国际放射医学核医学杂志,2016,40(2):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
Ma Le,Zhang Wanchun,Li Xiaomin.Evolution of radionuclide imaging of sentinel node lymphscintigraphy in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):145.[doi:10.3760/cma.j.issn.1673-4114.2016.02.012]
[3]陈伟君,孙达.99Tcm-MIBI显像在乳腺癌新辅助化疗中的应用价值[J].国际放射医学核医学杂志,2015,39(6):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
Chen Weijun,Sun Da.Clinical value of 99Tcm-MIBI imaging in neoadjuvant chemotherapy of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):487.[doi:10.3760/cma.j.issn.1673-4114.2015.06.011]
[4]胡鸿,唐刚华,聂大红.乳腺癌分子显像研究进展[J].国际放射医学核医学杂志,2015,39(1):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
Hu Hong,Tang Ganghua,Nie Dahong.Progress on molecular imaging of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):91.[doi:10.3760/cma.j.issn.1673-4114.2015.01.019]
[5]黄娟,颜剑豪,梁联保,等.注射钆剂后弥散加权成像对乳腺肿瘤诊断的影响[J].国际放射医学核医学杂志,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
Huang Juan,Yan Jianhao,Liang Lianbao,et al.Evaluation of the diffusion-weighted imaging after contrast for the characterization of breast tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):287.[doi:10.3760/cma.j.issn.1673-4114.2015.04.003]
[6]李雯,冯彦林.18F-FDG PET/CT评估三阴性乳腺癌新辅助化疗疗效的研究进展[J].国际放射医学核医学杂志,2014,38(3):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
Li Wen,Feng Yanlin.Advances of assessment with 18F-FDG PET/CT in triple-negative breast cancer during neoadjuvant chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):197.[doi:10.3760/cma.j.issn.1673-4114.2014.03.013]
[7]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[8]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[9]胡梦裳,章斌.PET/CT显像在乳腺癌疗效评价及预后中的作用[J].国际放射医学核医学杂志,2014,38(5):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
Hu Meng-shang,Zhang Bin.The role of PET/CT imaging in the evaluation of the efficacy and prognosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):332.[doi:10.3760/cma.j.issn.1673-4114.2014.05.013]
[10]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[11]储小飞,赵舒怡,樊赛军.肿瘤干细胞与辐射抗性的研究进展[J].国际放射医学核医学杂志,2015,39(5):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]
chu xiaofei,zhao shuyi,fan saijun..advance progress of cancer stem cells and radioresistance[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(4):431.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 019]